Trials / Sponsors / Aveta Biomics, Inc.
Aveta Biomics, Inc.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab Glioma, Glioblastoma Multiforme | Phase 1 / Phase 2 | 2023-12-13 |
| Active Not Recruiting | Safety and Efficacy of APG-157 in Head and Neck Cancer Head and Neck Cancer, Squamous Cell Carcinoma of Oral Cavity, Squamous Cell Carcinoma of the Oropharynx | Phase 2 | 2022-04-22 |
| No Longer Available | Treatment of Recurrent GBM With APG-157 Via Expanded Access Glioblastoma, Glioblastoma Multiforme | — | — |